REPORT DESCRIPTION
Tuberculosis Vaccine Market – Overview
Tuberculosis (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium
tuberculosis and is mostly spread through person to person contact. It causes multisystem infection and
eventually might lead to death of the infected person. Two types of TB that are commonly observed include
latent TB in which the infected person do not show symptoms and active TB in which the infected person
shows clinical symptoms of TB. Clinical symptoms and signs of TB include fever, night sweats, cough,
weight loss, hemoptysis (coughing up blood-stained sputum), fatigue, chest pain, and shortness of breath.
Depending upon the symptoms, TB may be classified as pulmonary TB, subcutaneous TB or military TB.
Depending on the resistance it shows, TB may be multidrug resistant TB or extended drug resistant TB.
Diagnosis of tuberculosis can be carried out using skin test, polymerase chain reaction test or interferon-
gamma release assays. Initial treatment regime for active TB includes drugs such as ethambutol,
pyrazinamide, isoniazid, and rifampicin.